Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:36 UTC |
---|
HMDB ID | HMDB0014379 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Reboxetine |
---|
Description | Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine. |
---|
Structure | [H][C@]1(CNCCO1)[C@@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1 InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(SS)-Reboxetine | HMDB | Reboxetine mesylate | HMDB | 2-((2-Ethoxyphenoxy)benzyl)morpholine methanesulfonate | HMDB | Vestra | HMDB | (+)-(2S)-2-((S)-(2-Ethoxyphenoxy)phenylmethyl)morpholine | HMDB | Reboxetine | MeSH |
|
---|
Chemical Formula | C19H23NO3 |
---|
Average Molecular Weight | 313.3908 |
---|
Monoisotopic Molecular Weight | 313.167793607 |
---|
IUPAC Name | (2S)-2-[(S)-2-ethoxyphenoxy(phenyl)methyl]morpholine |
---|
Traditional Name | reboxetine |
---|
CAS Registry Number | 98769-81-4 |
---|
SMILES | [H][C@]1(CNCCO1)[C@@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1 |
---|
InChI Key | CBQGYUDMJHNJBX-OALUTQOASA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenol ethers |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenol ethers |
---|
Alternative Parents | |
---|
Substituents | - Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Aralkylamine
- Monocyclic benzene moiety
- Morpholine
- Oxazinane
- Dialkyl ether
- Secondary aliphatic amine
- Ether
- Oxacycle
- Secondary amine
- Organoheterocyclic compound
- Azacycle
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 170 - 171 °C (mesylate salt) | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.022 g/L | Not Available | LogP | 3.1 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 174.0 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Reboxetine,1TMS,isomer #1 | CCOC1=CC=CC=C1O[C@@H](C1=CC=CC=C1)[C@@H]1CN([Si](C)(C)C)CCO1 | 2462.4 | Semi standard non polar | 33892256 | Reboxetine,1TMS,isomer #1 | CCOC1=CC=CC=C1O[C@@H](C1=CC=CC=C1)[C@@H]1CN([Si](C)(C)C)CCO1 | 2438.0 | Standard non polar | 33892256 | Reboxetine,1TMS,isomer #1 | CCOC1=CC=CC=C1O[C@@H](C1=CC=CC=C1)[C@@H]1CN([Si](C)(C)C)CCO1 | 3361.9 | Standard polar | 33892256 | Reboxetine,1TBDMS,isomer #1 | CCOC1=CC=CC=C1O[C@@H](C1=CC=CC=C1)[C@@H]1CN([Si](C)(C)C(C)(C)C)CCO1 | 2689.3 | Semi standard non polar | 33892256 | Reboxetine,1TBDMS,isomer #1 | CCOC1=CC=CC=C1O[C@@H](C1=CC=CC=C1)[C@@H]1CN([Si](C)(C)C(C)(C)C)CCO1 | 2620.6 | Standard non polar | 33892256 | Reboxetine,1TBDMS,isomer #1 | CCOC1=CC=CC=C1O[C@@H](C1=CC=CC=C1)[C@@H]1CN([Si](C)(C)C(C)(C)C)CCO1 | 3477.0 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Reboxetine GC-MS (Non-derivatized) - 70eV, Positive | splash10-002f-9510000000-c419747ac13882d22181 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Reboxetine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Reboxetine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 10V, Positive-QTOF | splash10-03di-0129000000-8a66fcd9f27a2e8d1e29 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 20V, Positive-QTOF | splash10-0h6r-1391000000-293a0b61cefb20d06e3d | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 40V, Positive-QTOF | splash10-05r3-9500000000-725ea11aada64c859bc4 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 10V, Negative-QTOF | splash10-03di-1249000000-0355482034f887fdfb23 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 20V, Negative-QTOF | splash10-03el-2693000000-66480f21ca5998c6d03c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 40V, Negative-QTOF | splash10-0a4l-7900000000-b34a81b04900dc0e1282 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 10V, Positive-QTOF | splash10-03di-0709000000-49770d96ddc33f490da6 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 20V, Positive-QTOF | splash10-01tc-6912000000-89667ca9f247b109629a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 40V, Positive-QTOF | splash10-002f-9600000000-500dfce79cc2fe29db26 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 10V, Negative-QTOF | splash10-03di-0319000000-650b49e0d4835471204c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 20V, Negative-QTOF | splash10-0a4i-0900000000-0085228a23971030ec0a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reboxetine 40V, Negative-QTOF | splash10-0a4i-4911000000-5c78e43b439b2c360e21 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00234 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00234 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB12395 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 59268 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Reboxetine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 65856 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 402799 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Kasper S, el Giamal N, Hilger E: Reboxetine: the first selective noradrenaline re-uptake inhibitor. Expert Opin Pharmacother. 2000 May;1(4):771-82. [PubMed:11249515 ]
- Edwards DM, Pellizzoni C, Breuel HP, Berardi A, Castelli MG, Frigerio E, Poggesi I, Rocchetti M, Dubini A, Strolin Benedetti M: Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding. Biopharm Drug Dispos. 1995 Aug;16(6):443-60. [PubMed:7579027 ]
- Wienkers LC, Allievi C, Hauer MJ, Wynalda MA: Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes. Drug Metab Dispos. 1999 Nov;27(11):1334-40. [PubMed:10534319 ]
- Fleishaker JC: Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression. Clin Pharmacokinet. 2000 Dec;39(6):413-27. [PubMed:11192474 ]
|
---|